×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Positron Emission Tomography Market

ID: MRFR/HC/42032-HCR
200 Pages
Garvit Vyas
October 2025

Positron Emission Tomography PET Market Research Report By Technology (Continuous Emission Tomography, Time-of-Flight PET, Full-Field PET), By Application (Oncology, Cardiology, Neurology, Radiology), By End Use (Hospitals, Diagnostic Centers, Research Institutions), By Product (Standalone PET Systems, Hybrid PET/CT Systems, Hybrid PET/MRI Systems) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Positron Emission Tomography Market Infographic
Purchase Options

Positron Emission Tomography Market Summary

As per MRFR analysis, the Positron Emission Tomography Market PET Market Size was estimated at 2.254 USD Billion in 2024. The Positron Emission Tomography Market PET industry is projected to grow from 2.385 in 2025 to 4.199 by 2035, exhibiting a compound annual growth rate (CAGR) of 5.82 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Positron Emission Tomography Market PET market is poised for substantial growth driven by technological advancements and increasing healthcare demands.

  • Technological advancements in imaging are enhancing the capabilities of Positron Emission Tomography Market systems.
  • The demand for early diagnosis is propelling the adoption of PET imaging, particularly in oncology, which remains the largest segment.
  • Asia-Pacific is emerging as the fastest-growing region, reflecting a surge in healthcare investments and infrastructure development.
  • Key market drivers include the increasing incidence of cancer and government initiatives aimed at promoting preventive healthcare.

Market Size & Forecast

2024 Market Size 2.254 (USD Billion)
2035 Market Size 4.199 (USD Billion)
CAGR (2025 - 2035) 5.82%

Major Players

Siemens Healthineers (DE), GE Healthcare (US), Philips Healthcare (NL), Canon Medical Systems (JP), Elekta (SE), Medtronic (US), United Imaging Healthcare (CN), Nuclear Imaging (US), Hitachi Medical Corporation (JP)

Positron Emission Tomography Market Trends

The Positron Emission Tomography Market PET Market is currently experiencing notable advancements driven by technological innovations and increasing demand for precise diagnostic tools. The integration of artificial intelligence and machine learning into PET imaging systems appears to enhance image quality and reduce scan times, thereby improving patient outcomes. Furthermore, the growing prevalence of chronic diseases necessitates early detection and monitoring, which PET technology is well-suited to address. As healthcare providers seek to optimize their diagnostic capabilities, the adoption of PET imaging is likely to expand, reflecting a shift towards more personalized medicine. In addition, the Positron Emission Tomography Market PET Market is witnessing a rise in collaborations between manufacturers and healthcare institutions. These partnerships aim to develop advanced imaging solutions that cater to specific clinical needs. Moreover, the increasing focus on research and development indicates a commitment to enhancing the efficacy of PET scans. As the market evolves, it seems poised for growth, driven by innovations that promise to transform diagnostic imaging and improve patient care.

Technological Advancements

The Positron Emission Tomography Market PET Market is benefiting from rapid technological advancements. Innovations in imaging technology, such as improved detectors and enhanced software algorithms, are likely to lead to better image resolution and faster processing times. These developments may facilitate more accurate diagnoses and treatment planning.

Growing Demand for Early Diagnosis

There is an increasing demand for early diagnosis of diseases, particularly cancer and neurological disorders. The Positron Emission Tomography Market PET Market appears to be responding to this need by providing tools that enable healthcare professionals to detect conditions at earlier stages, potentially improving treatment outcomes.

Collaborative Efforts in Research

Collaborative efforts between industry players and research institutions are becoming more prevalent in the Positron Emission Tomography Market PET Market. These partnerships aim to foster innovation and develop new applications for PET technology, which could lead to breakthroughs in various medical fields.

Positron Emission Tomography Market Drivers

Rising Geriatric Population

The increasing geriatric population is another significant factor influencing the Positron Emission Tomography Market PET Market. As individuals age, the prevalence of chronic diseases, including cancer and neurological disorders, tends to rise. PET imaging plays a crucial role in diagnosing and managing these conditions, making it an essential tool in geriatric healthcare. According to demographic projections, the global population aged 65 and older is expected to double by 2050, reaching approximately 1.5 billion. This demographic shift is likely to create a heightened demand for diagnostic imaging services, including PET scans, as healthcare systems adapt to the needs of an aging population. Consequently, the Positron Emission Tomography Market PET Market is poised for growth in response to these demographic changes.

Increasing Incidence of Cancer

The rising incidence of cancer worldwide is a critical driver for the Positron Emission Tomography Market PET Market. As cancer remains one of the leading causes of mortality, the demand for effective diagnostic tools is paramount. PET imaging is particularly valuable in oncology for tumor detection, staging, and monitoring treatment response. Recent statistics suggest that the number of new cancer cases is expected to reach 29.5 million by 2040, which underscores the urgent need for advanced imaging technologies. This growing patient population is likely to propel the demand for PET scans, thereby driving market growth. The Positron Emission Tomography Market PET Market is thus positioned to expand significantly as healthcare providers seek to implement more effective diagnostic strategies.

Government Initiatives and Funding

Government initiatives and funding aimed at enhancing healthcare infrastructure are pivotal drivers for the Positron Emission Tomography Market PET Market. Many countries are investing in advanced medical technologies to improve diagnostic capabilities and patient care. These investments often include funding for research and development in imaging technologies, as well as subsidies for healthcare facilities to acquire state-of-the-art equipment. For instance, various national health programs are increasingly recognizing the importance of PET imaging in early disease detection and management. This financial support is likely to stimulate market growth, as healthcare providers are more inclined to adopt PET technology. The Positron Emission Tomography Market PET Market stands to benefit significantly from these governmental efforts to bolster healthcare services.

Technological Advancements in Imaging

The Positron Emission Tomography Market PET Market is experiencing a surge in technological advancements that enhance imaging capabilities. Innovations such as hybrid imaging systems, which combine PET with computed tomography (CT) or magnetic resonance imaging (MRI), are becoming increasingly prevalent. These systems provide more accurate and comprehensive diagnostic information, thereby improving patient outcomes. The integration of artificial intelligence and machine learning algorithms into PET imaging is also on the rise, facilitating faster image processing and analysis. According to recent data, the market for advanced imaging technologies is projected to grow at a compound annual growth rate of over 10% in the coming years. This trend indicates a robust demand for sophisticated imaging solutions within the Positron Emission Tomography Market PET Market.

Growing Awareness of Preventive Healthcare

The growing awareness of preventive healthcare is driving demand within the Positron Emission Tomography Market PET Market. As patients and healthcare providers increasingly prioritize early detection and prevention of diseases, the role of advanced imaging technologies becomes more pronounced. PET scans are recognized for their ability to detect abnormalities at an early stage, which can lead to more effective treatment options. Public health campaigns and educational initiatives are contributing to this heightened awareness, encouraging individuals to seek regular screenings. Market data indicates that the preventive healthcare sector is expanding rapidly, with a projected growth rate of over 8% annually. This trend suggests that the Positron Emission Tomography Market PET Market will likely see increased utilization of PET imaging as part of routine health assessments.

Market Segment Insights

By Technology: Continuous Emission Tomography (Largest) vs. Time-of-Flight PET (Fastest-Growing)

In the Positron Emission Tomography Market (PET) market, Continuous Emission Tomography holds a significant portion of the market share, being the most widely adopted technology among imaging systems. Its established presence and reliability in clinical settings contribute to its dominance. However, Time-of-Flight PET is rapidly gaining traction, appealing to healthcare providers looking for enhanced image quality and accuracy, showcasing its robust market potential over other technologies.

Technology: Continuous Emission Tomography (Dominant) vs. Time-of-Flight PET (Emerging)

Continuous Emission Tomography is recognized for its reliability and precision in medical imaging, making it the dominant force in the PET market. Its long-standing use in diagnosing various conditions ensures a steady demand. In contrast, Time-of-Flight PET is emerging as a leading technology due to its ability to provide superior resolution and faster imaging capabilities. The increasing requirement for high-quality diagnostic imaging is driving its rapid growth, empowering facilities to enhance patient outcomes through more accurate diagnoses.

By Application: Oncology (Largest) vs. Cardiology (Fastest-Growing)

In the Positron Emission Tomography Market (PET) Market, oncology represents the largest application segment, capturing a substantial portion of market share. This market dominance is largely attributed to the increasing prevalence of cancer and the rising adoption of PET imaging for early detection and accurate diagnosis. Conversely, the cardiology segment, while comparatively smaller, is rapidly gaining traction as awareness around heart disease increases and advancements in imaging technologies enhance the capabilities of PET scans for cardiovascular assessments. Growth trends in the application segment are shaped by various factors, including technological advancements, increased healthcare expenditure, and expanding patient populations. The persistent focus on early diagnosis, particularly in oncology, further fuels the segment's growth. Moreover, cardiology is emerging as a pivotal area of interest, driven by the need for innovative imaging solutions that support effective treatment planning for heart diseases, marking it as a key growth segment within the PET market.

Oncology (Dominant) vs. Cardiology (Emerging)

Oncology, as the dominant application segment for the Positron Emission Tomography Market PET Market, is characterized by its pivotal role in cancer diagnosis and treatment monitoring. The application empowers healthcare professionals with advanced imaging capabilities, enabling them to detect malignancies at an early stage and assess treatment efficacy. Due to the significant rise in cancer cases globally, oncology's position is reinforced by continuous advancements that enhance the accuracy and reliability of PET imaging technologies. In contrast, cardiology is emerging as a significant sector within the PET market. While it has traditionally lagged behind oncology, recent advances in PET technology have allowed for improved visualization of cardiac conditions. This upward trajectory is supported by the rising burden of cardiovascular diseases, necessitating precise imaging methodologies for disease management and prevention, ultimately making cardiology a promising area for growth.

By End Use: Hospitals (Largest) vs. Diagnostic Centers (Fastest-Growing)

In the Positron Emission Tomography Market (PET) market, hospitals hold the largest market share among end use segments. This is primarily due to their extensive patient base and the integration of advanced imaging technologies in diagnostic procedures, making them a pivotal player in PET adoption. Diagnostic centers, while smaller in comparison, are rapidly capturing market attention, thanks to the increasing focus on early disease detection and outpatient imaging services.

Hospitals (Dominant) vs. Diagnostic Centers (Emerging)

Hospitals have been the dominant force in the PET market due to their capacity to invest in sophisticated equipment and provide comprehensive patient care. These institutions benefit from established relationships with healthcare providers and insurance companies, allowing for seamless integration of PET scans into diagnostic protocols. On the other hand, diagnostic centers, as emerging players, are gaining traction due to their ability to offer specialized imaging services tailored to patient needs, resulting in reduced wait times and more focused patient care. As these centers adopt cutting-edge PET technologies, they are poised for significant growth and a more prominent role in the market.

By Product: Hybrid PET/CT Systems (Largest) vs. Standalone PET Systems (Fastest-Growing)

In the Positron Emission Tomography Market (PET) market, hybrid PET/CT systems represent the largest segment, significantly influencing market dynamics due to their advanced imaging capabilities and integration of CT technology for enhanced diagnostic accuracy. Standalone PET systems, while smaller in market share, are rapidly gaining traction due to their suitability for specific applications and lower costs, appealing to a broader range of healthcare facilities. As technological advancements continue to shape the landscape, the distribution among these segment values is poised for further evolution. The growth trends within the PET market are primarily driven by increasing adoption rates of hybrid systems, which offer more comprehensive diagnostic information and improved patient outcomes. Concurrently, standalone PET systems are experiencing a surge in demand as healthcare providers recognize their cost-effectiveness and simplicity for routine scans. The interplay between these segment values highlights a diverse landscape where innovation and efficiency are paramount in catering to clinical needs.

Hybrid PET/CT Systems (Dominant) vs. Standalone PET Systems (Emerging)

Hybrid PET/CT systems dominate the Positron Emission Tomography Market due to their ability to provide combined functional and anatomical imaging, leading to improved diagnostic accuracy and treatment planning. These systems are highly regarded in oncology, cardiology, and neurology. In contrast, standalone PET systems are emerging as a viable option particularly for facilities seeking cost-effective solutions for routine imaging and research applications. While they may not offer the advanced features of hybrid systems, standalone units are valued for their reliability and user-friendliness, making them an attractive choice for smaller practices and diagnostic centers exploring PET imaging capabilities.

Get more detailed insights about Positron Emission Tomography Market

Regional Insights

The Global Positron Emission Tomography Market (PET) Market is expected to reach a valuation of 2.26 USD Billion in 2024 and grow significantly by 2035, further illustrating the robust nature of this industry. Within the regional landscape, North America is projected to dominate with a market value of 0.94 USD Billion in 2024, growing to 1.75 USD Billion by 2035, highlighting its majority holding in the Global Positron Emission Tomography Market PET Market.

Europe follows with a valuation of 0.68 USD Billion in 2024, expected to increase to 1.29 USD Billion by 2035, indicating its significant role.The Asia-Pacific (APAC) region is seen with values of 0.54 USD Billion in 2024 and reaching 1.01 USD Billion by 2035, reflecting its growing adoption of PET technology due to advancements in healthcare infrastructure.

South America presents a smaller yet essential market, valued at 0.06 USD Billion in 2024 and expected to rise to 0.11 USD Billion by 2035. Similarly, the Middle East and Africa (MEA) region is valued at 0.04 USD Billion in 2024, anticipated to reach 0.08 USD Billion by 2035, showing its emerging importance in the Global Positron Emission Tomography Market PET Market landscape.These figures underscore the ongoing developments and potential opportunities across various regions, driven by increasing healthcare needs and technological advancements in imaging technologies.

Positron Emission Tomography Market Pet Market Region

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Positron Emission Tomography Market Regional Image

Key Players and Competitive Insights

The Global Positron Emission Tomography Market (PET) Market has become increasingly competitive due to advancements in imaging technology, increased healthcare expenditure, and an expanding patient population that requires diagnostic imaging services. As the market continues to evolve, companies are adopting innovative strategies to maintain market share and gain a competitive edge.

With the rising demand for accurate and efficient diagnostic tools, key players are focusing on enhancing the capabilities of PET systems, exploring collaborations for technological advancements, investing in research and development, and expanding their product offerings.

Additionally, regulatory approvals and compliance play a significant role in shaping the competitive dynamics of this market. As organizations continuously strive to differentiate themselves, understanding product performance, customer needs, and market trends is crucial for successful operation within this growing field.Zonare Medical Systems has established a notable presence in the Global Positron Emission Tomography Market PET Market primarily due to its advanced imaging technologies and commitment to innovation.

The company is known for its unique and versatile ultrasound system that provides exceptional image quality and efficiency, which is a critical aspect in the realm of diagnostic imaging, including PET.

Zonare Medical Systems focuses on fostering strong relationships with healthcare providers and investing in training programs to ensure that medical professionals are equipped to utilize their imaging systems effectively. Their strengths lie in their ability to enhance patient care through state-of-the-art imaging solutions that assist in early diagnosis and treatment planning.

Zonare’s dedication to innovation and quality positions it favorably in the competitive landscape of medical imaging, making it a valuable player in the PET market.Varex Imaging is a significant contributor to the Global Positron Emission Tomography Market PET Market, recognized for its broad portfolio of imaging products and components that play a critical role in PET systems.

The company specializes in the development and production of high-quality X-ray imaging components, which are integral to PET technology. Varex Imaging’s strengths include a strong emphasis on research and development geared towards the enhancement of imaging quality and system performance, thus catering to the increasing demands of healthcare professionals.

Their global presence and extensive distribution network facilitate an effective reach to various healthcare providers, ensuring that their innovative solutions are widely accessible. Varex Imaging’s dedication to advancing imaging technology, combined with its robust market presence, strengthens its competitive position in the evolving PET landscape.

Key Companies in the Positron Emission Tomography Market market include

Industry Developments

  • Q2 2024: Siemens Healthineers launches Biograph Vision.X PET/CT scanner with enhanced time-of-flight technology Siemens Healthineers announced the commercial launch of its Biograph Vision.X PET/CT scanner, featuring improved time-of-flight performance for higher image quality and faster scan times, targeting oncology and neurology imaging applications.
  • Q2 2024: GE HealthCare receives FDA 510(k) clearance for Omni Legend PET/CT system GE HealthCare announced it has received FDA 510(k) clearance for its Omni Legend PET/CT system, which incorporates digital detector technology to improve sensitivity and workflow efficiency in clinical PET imaging.
  • Q1 2024: Philips launches next-generation Vereos Digital PET/CT system Philips introduced its new Vereos Digital PET/CT system, designed to deliver higher resolution images and lower radiation doses, supporting advanced oncology and cardiac imaging.
  • Q2 2024: Canon Medical Systems opens new PET/CT manufacturing facility in Ohio Canon Medical Systems announced the opening of a new manufacturing facility in Ohio dedicated to the production of PET/CT scanners, aiming to meet growing demand in North America.
  • Q1 2024: Siemens Healthineers and Telix Pharmaceuticals announce strategic partnership to advance PET imaging in oncology Siemens Healthineers and Telix Pharmaceuticals entered a strategic partnership to co-develop and commercialize new PET imaging solutions for cancer diagnosis and treatment monitoring.
  • Q2 2024: United Imaging Healthcare receives CE Mark for uMI Panorama PET/CT system United Imaging Healthcare announced it has received CE Mark approval for its uMI Panorama PET/CT system, enabling commercialization in the European Union.
  • Q1 2024: Siemens Healthineers acquires PET radiopharmaceutical production facility in Germany Siemens Healthineers completed the acquisition of a PET radiopharmaceutical production facility in Germany to expand its supply chain and support the growing demand for PET tracers.
  • Q2 2024: GE HealthCare and SOFIE Biosciences announce collaboration to develop novel PET radiotracers GE HealthCare and SOFIE Biosciences announced a collaboration to co-develop and commercialize new PET radiotracers for oncology and neurology applications.
  • Q1 2024: Philips and Bracco Imaging sign agreement to jointly develop PET imaging agents Philips and Bracco Imaging signed an agreement to jointly develop and commercialize new PET imaging agents, aiming to enhance diagnostic capabilities in oncology and neurology.
  • Q2 2024: United Imaging Healthcare opens new R&D center for PET/CT technology in Shanghai United Imaging Healthcare inaugurated a new research and development center in Shanghai focused on advancing PET/CT scanner technology and radiopharmaceutical innovation.
  • Q1 2024: Canon Medical Systems receives FDA clearance for Celesteion PET/CT system Canon Medical Systems announced it has received FDA clearance for its Celesteion PET/CT system, designed to provide high-quality imaging for oncology and cardiology applications.
  • Q2 2024: GE HealthCare announces $100 million investment in PET radiopharmaceutical manufacturing expansion GE HealthCare announced a $100 million investment to expand its PET radiopharmaceutical manufacturing capacity in the United States, aiming to support increased demand for PET imaging agents.

Future Outlook

Positron Emission Tomography Market Future Outlook

The Positron Emission Tomography Market PET Market is projected to grow at a 5.82% CAGR from 2024 to 2035, driven by technological advancements, increasing cancer prevalence, and rising healthcare expenditure.

New opportunities lie in:

  • Development of portable PET imaging devices for remote diagnostics.
  • Integration of AI algorithms for enhanced image analysis and interpretation.
  • Expansion of PET applications in personalized medicine and drug development.

By 2035, the PET market is expected to achieve substantial growth, reflecting advancements and increased adoption across healthcare sectors.

Market Segmentation

Positron Emission Tomography Market End Use Outlook

  • Hospitals
  • Diagnostic Centers
  • Research Institutions

Positron Emission Tomography Market Product Outlook

  • Standalone PET Systems
  • Hybrid PET/CT Systems
  • Hybrid PET/MRI Systems

Positron Emission Tomography Market Technology Outlook

  • Continuous Emission Tomography
  • Time-of-Flight PET
  • Full-Field PET

Positron Emission Tomography Market Application Outlook

  • Oncology
  • Cardiology
  • Neurology
  • Radiology

Report Scope

MARKET SIZE 20242.254(USD Billion)
MARKET SIZE 20252.385(USD Billion)
MARKET SIZE 20354.199(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.82% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesAdvancements in artificial intelligence enhance diagnostic accuracy in the Positron Emission Tomography PET Market.
Key Market DynamicsTechnological advancements in imaging techniques drive competitive dynamics in the Positron Emission Tomography market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Leave a Comment

FAQs

What is the projected market valuation of the Positron Emission Tomography PET Market by 2035?

The Positron Emission Tomography PET Market is projected to reach a valuation of 4.199 USD Billion by 2035.

What was the market valuation of the Positron Emission Tomography PET Market in 2024?

In 2024, the market valuation of the Positron Emission Tomography PET Market was 2.254 USD Billion.

What is the expected CAGR for the Positron Emission Tomography PET Market during the forecast period 2025 - 2035?

The expected CAGR for the Positron Emission Tomography PET Market during the forecast period 2025 - 2035 is 5.82%.

Which technology segment is projected to have the highest valuation in 2035?

The Hybrid PET/CT Systems segment is projected to reach a valuation of 2.2 USD Billion by 2035.

What are the key applications driving the Positron Emission Tomography PET Market?

Key applications include Oncology, Cardiology, Neurology, and Radiology, with Oncology projected to reach 1.675 USD Billion by 2035.

Which end-use segment is expected to dominate the market by 2035?

The Hospitals segment is expected to dominate the market, projected to reach 1.688 USD Billion by 2035.

Who are the leading players in the Positron Emission Tomography PET Market?

Key players in the market include Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems.

What is the projected valuation for the Time-of-Flight PET segment by 2035?

The Time-of-Flight PET segment is projected to reach a valuation of 1.239 USD Billion by 2035.

How does the market valuation of Full-Field PET compare to other segments by 2035?

The Full-Field PET segment is projected to reach 1.724 USD Billion by 2035, indicating strong growth relative to other segments.

What is the expected growth trend for Diagnostic Centers in the Positron Emission Tomography PET Market?

The Diagnostic Centers segment is projected to grow to 1.267 USD Billion by 2035, reflecting a positive growth trend.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions